芪桂升板方治疗慢性免疫性血小板减少症32例临床研究  

Clinical Research on Qiguishengbanfang for Immune Thrombocytopenia:A Report of 34 Cases

作　　者：张雪娟[1] 王春秀[1] 

机构地区：[1]河北省中医院,河北石家庄500011

出　　处：《辽宁中医杂志》2012年第12期2427-2428,共2页Liaoning Journal of Traditional Chinese Medicine

基　　金：河北省中医药管理局指令计划(2010030)

摘　　要：目的:观察自拟芪桂升板方治疗慢性免疫性血小板减少症的临床疗效。方法:将60例患者随机分为2组,治疗组32例采用芪桂升板方(组成:黄芪、桂枝、生地、制首乌、防风、赤芍、人参、白术、茯苓、女贞子、仙灵脾、巴戟天、生甘草)治疗,对照组28例,用达那唑联合氨太素治疗,疗程均为3个月。结果:总有效率治疗组为87.5%,对照组为42.9%,二者比较差异有显著性意义(P<0.01)。而且,治疗组能明显降低血小板抗体水平,提高患者调节性T细胞水平,并且提升白细胞水平。结论:芪桂升板方治疗慢性免疫性血小板减少症疗效确切,而且能提高患者免疫力,值得临床推广。Objective：To observe the therapeutic effect of Qiguishengbanfang on chronicity immune thrombocytopenia. Methods：Tatally 60 ITP patients were randomized into 2 group, treatment groups 32 cases were given Qiguishengbanfang（ composition： Mongolian Milkvetch Root ,Cassiabarktree Twig ,rehmannia dride rhizome, Radix Polygoni Muhiflori, Divaricate Saposhnikovia, Red Peony Root, Ginseng, largehead atractylodes rhizome, tuckahoe, Glossy Privet Fruit, Herba Epimedii, Medicinal Morinda Root, Liquorice Root）. Control group 28 cases, were given danazol combined with Antaisu, course of treatment was 3 months. Results：The effective rate of the treatment group is 87.5% , control group is 42.9% ,There was significant difference to comparetwo groups（P 〈0.01 ）,and the treatment group has obviously low platelet antibody level, enhance regulative T cell and leucocyte. Conclusion：The Qiguishengbanfang has definite curative effect for chronicity immune thrombocytopenia and Improve patients im- munity,, deserve to extend in clinic.

关 键 词：芪桂升板方 慢性免疫性血小板减少症 血小板抗体 调节性T细胞 

分 类 号：R558.2[医药卫生—血液循环系统疾病]